Designer cytokines: Targeting actions to cells of choice Journal Article


Authors: Economides, A. N.; Ravetch, J. V.; Yancopoulos, G. D.; Stahl, N.
Article Title: Designer cytokines: Targeting actions to cells of choice
Abstract: Some growth factors are therapeutically useful partly because restricted expression of their receptors limits their action to particular cell types. However, no unique stimulatory factor is known for many clinically relevant cell types, such as CD34+ hematopoietic stem cells. Here, soluble α receptor (Ra) components for interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) were targeted in an active form to cells expressing surface markers such as CD34 or CD45, thereby rendering those cells responsive to IL-6 or CNTF. The targeting of Ra components may provide the means to create "designer" cytokines that activate a desired cell type expressing a specific cell surface marker.
Keywords: animal; cell division; cd34 antigen; cell line; nerve tissue proteins; tumor cells, cultured; phosphorylation; cell type; cytokine; antibodies, monoclonal; membrane glycoproteins; cell surface marker; cell membrane; interleukin 6; interleukin-6; hematopoietic stem cell; antigens, cd; antigens, cd34; cd45 antigen; solubility; antigens, cd45; receptors, nerve growth factor; interleukin receptor; receptors, fc; receptors, cytokine; receptors, interleukin-6; receptors, interleukin; human; priority journal; article; ciliary neurotrophic factor; chimeric proteins; receptor, ciliary neurotrophic factor; immunoglobulins, fc
Journal Title: Science
Volume: 270
Issue: 5240
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 1995-11-24
Start Page: 1351
End Page: 1353
Language: English
DOI: 10.1126/science.270.5240.1351
PUBMED: 7481821
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jeffrey V. Ravetch
    72 Ravetch